| 1 | 1 | | 1 of 1 |
|---|
| 2 | 2 | | HOUSE DOCKET, NO. 3151 FILED ON: 1/20/2023 |
|---|
| 3 | 3 | | HOUSE . . . . . . . . . . . . . . . No. 2165 |
|---|
| 4 | 4 | | The Commonwealth of Massachusetts |
|---|
| 5 | 5 | | _________________ |
|---|
| 6 | 6 | | PRESENTED BY: |
|---|
| 7 | 7 | | Carole A. Fiola |
|---|
| 8 | 8 | | _________________ |
|---|
| 9 | 9 | | To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General |
|---|
| 10 | 10 | | Court assembled: |
|---|
| 11 | 11 | | The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill: |
|---|
| 12 | 12 | | An Act to reduce fraud in prescription drug abuse testing and help prevent substance abuse. |
|---|
| 13 | 13 | | _______________ |
|---|
| 14 | 14 | | PETITION OF: |
|---|
| 15 | 15 | | NAME:DISTRICT/ADDRESS :DATE ADDED:Carole A. Fiola6th Bristol1/12/2023Paul A. Schmid, III8th Bristol2/1/2023 1 of 2 |
|---|
| 16 | 16 | | HOUSE DOCKET, NO. 3151 FILED ON: 1/20/2023 |
|---|
| 17 | 17 | | HOUSE . . . . . . . . . . . . . . . No. 2165 |
|---|
| 18 | 18 | | By Representative Fiola of Fall River, a petition (accompanied by bill, House, No. 2165) of |
|---|
| 19 | 19 | | Carole A. Fiola and Paul A. Schmid, III that the Office of Medicaid be authorized to require |
|---|
| 20 | 20 | | laboratories providing toxicology testing to demonstrate functional and operational test- |
|---|
| 21 | 21 | | utilization and test-frequency control programs. Public Health. |
|---|
| 22 | 22 | | [SIMILAR MATTER FILED IN PREVIOUS SESSION |
|---|
| 23 | 23 | | SEE HOUSE, NO. 2286 OF 2021-2022.] |
|---|
| 24 | 24 | | The Commonwealth of Massachusetts |
|---|
| 25 | 25 | | _______________ |
|---|
| 26 | 26 | | In the One Hundred and Ninety-Third General Court |
|---|
| 27 | 27 | | (2023-2024) |
|---|
| 28 | 28 | | _______________ |
|---|
| 29 | 29 | | An Act to reduce fraud in prescription drug abuse testing and help prevent substance abuse. |
|---|
| 30 | 30 | | Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority |
|---|
| 31 | 31 | | of the same, as follows: |
|---|
| 32 | 32 | | 1 SECTION ##. Chapter 118E of the general laws is hereby amended by adding at the end |
|---|
| 33 | 33 | | 2thereof the following new Section: |
|---|
| 34 | 34 | | 3 SECTION ##. To ensure appropriate and responsible use of drug testing, for laboratories |
|---|
| 35 | 35 | | 4providing toxicology testing, the Office of Medicaid is authorized to require that these providers |
|---|
| 36 | 36 | | 5demonstrate a functional and operational test-utilization and test-frequency control program that |
|---|
| 37 | 37 | | 6will ensure compliance with MassHealth’s utilization and frequency requirements for clinical |
|---|
| 38 | 38 | | 7drug testing. |
|---|
| 39 | 39 | | 8 Notwithstanding any general or special law to the contrary, an independent clinical |
|---|
| 40 | 40 | | 9laboratory, licensed under the Clinical Laboratory Improvement Amendments (CLIA) by the 2 of 2 |
|---|
| 41 | 41 | | 10U.S. Centers for Medicare and Medicaid (CMS) that is located out-of-state and accredited by |
|---|
| 42 | 42 | | 11both the College of American Pathologists (CAP) and the New York State Clinical Laboratory |
|---|
| 43 | 43 | | 12Evaluation Program (CLEP), and providing and being reimbursed for managed Medicaid |
|---|
| 44 | 44 | | 13services in Massachusetts, shall be deemed eligible and qualified to participate as a MassHealth |
|---|
| 45 | 45 | | 14fee-for-service provider and eligible for payment for clinical toxicology testing purposes. |
|---|
| 46 | 46 | | 15Payments made to qualified laboratories under this section will only apply when a qualified |
|---|
| 47 | 47 | | 16laboratory provides toxicology test results to the referring health care provider within two |
|---|
| 48 | 48 | | 17business days of receipt of the test specimen. |
|---|